Get the Stockscreener App
1.10
5.17%
-0.06
Oncology Institute Inc stock is currently priced at $1.10, with a 24-hour trading volume of 223.85K.
It has seen a -5.17% decreased in the last 24 hours and a -26.17% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $1.17 pivot point. If it approaches the $1.08 support level, significant changes may occur.
Previous Close:
$1.16
Open:
$1.25
24h Volume:
223.85K
Market Cap:
$89.18M
Revenue:
$324.24M
Net Income/Loss:
$-83.07M
P/E Ratio:
-1.3095
EPS:
-0.84
Net Cash Flow:
$-40.88M
1W Performance:
-4.35%
1M Performance:
-26.17%
6M Performance:
-45.54%
1Y Performance:
+126.76%
1D Range:
$1.06
$1.25
52W Range:
$0.33
$2.655
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
213 760 1328
Address
18000 Studebaker Road, Suite 800, Cerritos
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
Oncology Institute Inc Stock (TOI) Latest News
Constellation Software Inc. and Topicus.com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2024
GlobeNewswire Inc.
Topicus.com Inc. Announces Release Date for First Quarter Results
GlobeNewswire Inc.
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
GlobeNewswire Inc.
The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
GlobeNewswire Inc.
Down -23.64% in 4 Weeks, Here's Why The Oncology Institute (TOI) Looks Ripe for a Turnaround
Zacks Investment Research
MaxHealth & The Oncology Institute Expand Value-Based Care Partnership
GlobeNewswire Inc.
Oncology Institute Inc Stock (TOI) Financials Data
Oncology Institute Inc (TOI) Revenue 2024
TOI reported a revenue (TTM) of $324.24 million for the quarter ending December 31, 2023, a +28.42% rise year-over-year.
Oncology Institute Inc (TOI) Net Income 2024
TOI net income (TTM) was -$83.07 million for the quarter ending December 31, 2023, a -54,750% decrease year-over-year.
Oncology Institute Inc (TOI) Cash Flow 2024
TOI recorded a free cash flow (TTM) of -$40.88 million for the quarter ending December 31, 2023, a +39.24% increase year-over-year.
Oncology Institute Inc (TOI) Earnings per Share 2024
TOI earnings per share (TTM) was -$0.92 for the quarter ending December 31, 2023, a -441.18% decline year-over-year.
About Oncology Institute Inc
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
0.94%
0.37%
Cap:
|
Volume (24h):